CN101361952A - Traditional Chinese medicine preparation for treating cold - Google Patents
Traditional Chinese medicine preparation for treating cold Download PDFInfo
- Publication number
- CN101361952A CN101361952A CNA2008100729548A CN200810072954A CN101361952A CN 101361952 A CN101361952 A CN 101361952A CN A2008100729548 A CNA2008100729548 A CN A2008100729548A CN 200810072954 A CN200810072954 A CN 200810072954A CN 101361952 A CN101361952 A CN 101361952A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- drug
- chinese medicine
- weight portion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the field of Chinese medicine production, in particular to a Chinese drug preparation for treating cold by using Chinese medicinal herbs, which consists of four drugs including a monarch drug, a ministerial drug, an adjuvant drug and an envoy drug, and is an oral preparation prepared by the existing conventional Chinese medicine production technique and accessories, wherein, the ingredients of the Chinese medicine are as follows: herba schizeneptae, divaricate saposhnikovia root, rhizoma et radix notopterygii, radix angelicae tuhuo, radix bupleuri, rhizoma ligustici wallichii, radix codonopsis pilosulae, fructus aurantii, radices platycodi, cicada slough, bombyx batryticatus, scorpio, centipede, woad root of dyer, ginger, liquorice, radices peucedani and corn mint. The Chinese drug preparation has relatively satisfactory curative effects on improving various symptoms caused by cold, such as fever, headache, runny nose, sore throat, and the like, with a recovery rate reaching 70 percent and total effective rate reaching 95 percent.
Description
Technical field
The present invention relates to field of traditional Chinese medicine pharmacy, relate to Chinese medicine preparation particularly with the Chinese herbal treatment flu.
Background technology
Flu is a kind of spring, summer, autumn and winter season alternation common disease, especially frequently-occurring disease when there's a sudden fall in temperature when changing.Adult's flu is caused by rhinovirus and coronavirus mostly.The rhinovirus transmissibility is very strong, and the infection rate height how at autumn, throttling in spring row, is the main virus that causes flu.Coronavirus is comparatively common with winter, does not also have the specific treatment medicine so far.Sneeze, fever, headache, watery nasal discharge, nasal obstruction appear in regular meeting during flu, symptoms such as laryngopharynx swelling and pain, and the regular meeting of catching a cold constantly brings out diseases such as chronic bronchial, pneumonia.
At present commercially available Coritab is numerous in variety, mostly is compound preparation, and compound preparation mainly is to utilize between the various medicines to have synergism, brings into play the advantage of each medicine, reaches the purpose of symptomatic treatment.Though aspect the symptoms such as the headache that chemicals causes because of flu in alleviation, heating, cough, nasal obstruction, watery nasal discharge, sneeze curative effect is preferably arranged, it mainly is a relief of symptoms, and the cold medicine that majority of compounds is made all brings bigger side effect.Though the high side effect of the natural degree of Chinese medicine is low, the patient tends to abandon the low Chinese medicine of toxic and side effects and selects the bigger combination drug of side effect to treat flu, in the hope of quick relief of symptoms.
Motherland's traditional Chinese medical science medical science extensive knowledge and profound scholarship, the traditional Chinese medical science adopt traditional Chinese herbal medicine to treat this disease, can reach the effect for the treatment of both the principal and secondary aspects of a disease.The traditional Chinese medical science is thought: " in vital qi deposited, heresy can not be done.", because of being vital qi weakness in the human body, due to resistance against diseases descended, exopathogenic factor was then invaded because of cold and is caused by cold virus within the flu morbidity.Therefore, treatment flu is when starting with from this two aspect, and training is mended replenishing vital QI with drugs of warm nature human body vital qi strengthening the resistance against diseases of self on the one hand, and suitably improves the body temperature diaphoresis; Alleviate in addition or eliminate due to illness fever, headache, watery nasal discharge, the nasal obstruction that poison causes, various bad diseases such as laryngopharynx swelling and pain.
Through State Intellectual Property Office's internet retrieval, the Chinese medicinal composition preparation that much relates to treatment flu is arranged, below only choose two examples, prior art as a comparison:
Documents 1: " a kind of wind expelling common cold oral liquid and preparation method thereof ", its Granted publication number: CN1310655C, open day be: 2005.08.10 Granted publication day is: 2007.4.18, this disclosure of the Invention " a kind of wind expelling common cold oral liquid for the treatment of upper respiratory tract infection wind and cold disease and preparation method thereof; it is characterized in that crude drug is by Folium Perillae; Rhizoma Et Radix Notopterygii; Herba Schizonepetae; Herba Pogostemonis; Radix Saposhnikoviae, Herba Spirodelae, Radix Peucedani, Cortex Sclerotii Poriae is formed, Folium Perillae wherein, Rhizoma Et Radix Notopterygii, Herba Schizonepetae, Herba Pogostemonis, decocting boils behind Radix Saposhnikoviae distillating extracting oil and the Aromatic water, Herba Spirodelae, Radix Peucedani, Cortex Sclerotii Poriae decocts with water, above water extract merges, concentrate, centrifugal filtration, add volatile oil, Aromatic water and pharmaceutic adjuvant are prepared from, and clinical experiment shows that wind expelling common cold oral liquid of the present invention has curative effect preferably.", its major defect is: this side is an incomplete Antiphlogistic Powder of Schizonepetae and Ledebouriellae.Antiphlogistic Powder of Schizonepetae and Ledebouriellae is famous effective prescription that the traditional Chinese medical science is used for treating anemofrigid cold, and its prescription is rigorous, and curative effect has experienced the century-old clinical verification of book.And above-mentioned prescription has destroyed the principle of former prescription, cutting as the Radix Angelicae Pubescentis of monarch drug with as the Radix Bupleuri of ministerial drug, make the power of expelling wind and cold pathogens subtract greatly, next has deducted as the Fructus Aurantii of adjuvant drug and Radix Platycodonis, destroyed the effect that cooperatively interacts of the dispersing and descending lung-QI of treatment flu in the side, thereby further reduced the curative effect of treatment anemofrigid cold, so this side is a not Chinese prescription medicament of science very.
Documents 2: " medicine of cold-treating influenza-preventing ", its Granted publication number: CN 100355451C, open day 2006.10.4, Granted publication day is: 2007.12.19, this disclosure of the Invention " the invention belongs to technical field of Chinese medicines, specifically is a kind of medicine of cold-treating influenza-preventing, its short treating period; evident in efficacy, and medical expense is low.The medicament of making by the raw material of following weight ratio: Radix Isatidis 1-8 gram, Radix Scutellariae 1-6 gram, Flos Chrysanthemi 0.5-7 gram, Flos Lonicerae 3-13 gram, Folium Perillae 5-15 gram, Ramulus Cinnamomi 5-15 gram, Herba Pogostemonis 5-10 gram, Herba Schizonepetae 1-5 part, Rhizoma Et Radix Notopterygii 2-5 gram, Radix Saposhnikoviae 1-5 gram, Radix Angelicae Dahuricae 1-5 gram, Rhizoma Zingiberis Recens 1-3 gram, Herba Violae 0.3-5 gram, Herba Taraxaci 0.5-4 part, Radix Scrophulariae 1-5 gram, very light blue 2-8 gram.The present invention be the inventor in the past few years through the pure Chinese medicine product of test of many times development, take through many people are clinical, works very well is taken before the influenza, effect duration reached more than 85 days.Ill taking can in time be cured, and takes to begin to take effect in 30 minutes, takes and can cure fully in 30-45 hour, and effective percentage reaches more than 95%.", its major defect is: this side is a medicine that pungent and cold medicine for relieving the exterior syndrome, heat and toxic materials clearing away medicine and pungent and warm medicine for relieving the exterior syndrome piece together, and lacks the principles of formulating prescriptions of differentiation of tcm, so clinically do not have a too superior curative effect.From traditional Chinese medical science compatibility angle, this side lacks the art of composition, and difficulty has satisfied effect.
I find by clinical practice for many years, the Radix Codonopsis invigorating the spleen and replenishing QI, the effect of spleen invigorating lung benefiting, in diseases such as treatment flu, has unique effect, use and,, have really and unique therapeutical effect by clinical alleviating diseases such as " fever headache, watery nasal discharge nasal obstructions; laryngopharynx swelling and pain " to the optimum organization of compatibility.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of Chinese medicine preparation with therapeutic effect obvious treatment flu safe in utilization.
The present invention's technical scheme disclosed and protection is: the Chinese medicine preparation of treatment flu is characterized in the oral formulations of being formed and being made by following bulk drugs employing existing conventional pharmaceutical technology (tcd) and adjuvant by monarch drug, ministerial drug, adjuvant drug and messenger drug four class medicines; Wherein, the monarch drug weight portion is: Herba Schizonepetae 8-12 part, Radix Saposhnikoviae 8-12 part, Rhizoma Et Radix Notopterygii 12-18 part, Radix Angelicae Pubescentis 8-12 part; The ministerial drug weight portion is: Radix Bupleuri 8-12 part, Rhizoma Chuanxiong 8-12 part, Radix Codonopsis 12-18 part, Poria 8-12 part; The adjuvant drug weight portion is: Fructus Aurantii 8-12 part, Radix Platycodonis 4-6 part, Periostracum Cicadae 8-12 part, Bombyx Batryticatus 8-12 part, Scorpio 4-6 part, Scolopendra 4-6 part, Radix Isatidis 25-35 part; The messenger drug weight portion is: Rhizoma Zingiberis Recens 4-6 part, Radix Glycyrrhizae 8-12 part, Radix Peucedani 8-12 part, Herba Menthae 8-12 part.
As improvement of the technical scheme, wherein preferred, the monarch drug weight portion is: 10 parts of Herba Schizonepetae, 10 parts of Radix Saposhnikoviaes, 15 parts of Rhizoma Et Radix Notopterygiis, 10 parts of Radix Angelicae Pubescentiss; The ministerial drug weight portion is: 10 parts of Radix Bupleuri, 10 parts of Rhizoma Chuanxiongs, 15 parts of Radix Codonopsis, 10 parts in Poria; The adjuvant drug weight portion is: 10 parts of Fructus Aurantiis, 5 parts of Radix Platycodoniss, 10 parts of Periostracum Cicadae, 10 parts of Bombyx Batryticatus, 5 parts of Scorpio, 5 parts of Scolopendras, 30 parts of Radix Isatidis; The messenger drug weight portion is: 5 parts in Rhizoma Zingiberis Recens, 10 parts in Radix Glycyrrhizae, 10 parts of Radix Peucedanis, 10 parts of Herba Menthaes.
Combination according to the crude drug of above-mentioned composition form of the present invention, mix with the multi-form auxiliary adding ingredient of acceptable in the oral drug preparation and corresponding the processing after, can be made into the oral drugs of corresponding different dosage forms with existing conventional pharmaceutical technology (tcd) and adjuvant, as the oral drugs of pill, granule, capsule, powder, tablet or other solid preparation form; Can also make oral drugs as liquid preparation forms such as water decoction, syrup.
The present invention is made up of 19 flavor Chinese medicines, and its compatibility characteristics are expelling cold and relieving exterior syndromes, cure mainly wind and cold diseases caused by exogenous pathogenic factor disease.Wherein, Herba Schizonepetae, Radix Saposhnikoviae, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis loosing the interspaces of skin and muscles, it is cold to dispel the wind, and Xin Wen disperses, but extensively treating wind-cold damp pathogen and be monarch all over the body up and down; The Rhizoma Chuanxiong circulation of qi promoting is dispeled the wind, and Radix Bupleuri is evacuated expelling pathogenic factors from muscles, Poria spleen invigorating eliminating dampness by diuresis, and it is to be ministerial drug that the Radix Codonopsis QI invigorating is set upright the diffusing exopathogen of principal drug assistance; Fructus Aurantii and Radix Platycodonis can be declared catharsis, and the tonneau throat is to be assistant but Periostracum Cicadae, Bombyx Batryticatus, Scorpio, Scolopendra and Radix Isatidis expelling wind to relieve convulsion remove pain; Hot the loosing of Rhizoma Zingiberis Recens is supporing yang product, but Herba Menthae walks the table dispelling wind and heat pathogens, the Radix Peucedani wind heat clearing away of loosing, and lowering the adverse-rising QI to resolve phlegm, Radix Glycyrrhizae energy warming the middle warmer and descending qi, cough-relieving are quenched the thirst, and coordinating the actions of various ingredients in a prescription is to be messenger drug; All medicine compatibilities are played temperature compensation human body vital qi altogether, and strengthening vital QI to eliminate pathogenic factors improves the body disease-resistant function, with reach analgesic, ease pain, eliminate the phlegm, the effect of antitussive.
The Chinese crude drug effect of each component of the present invention:
Herba Schizonepetae-expelling pathogenic wind from the body surface is furnished with the merit of the space between skin and muscles of reaching, Pulvis Diaphoreticus heresy mutually with Radix Saposhnikoviae; Be equipped with Herba Menthae again, to strengthen the effect of relieving the exterior syndrome by diaphoresis.
Radix Saposhnikoviae-inducing diaphoresis to dispel wind is usually used in headache due to common cold, the rubella pruritus.
Rhizoma Et Radix Notopterygii-expelling cold and relieving exterior syndrome, wind-damp dispelling, pain relieving; Be usually used in anemofrigid cold, the headache body is painful.
Radix Angelicae Pubescentis-dispelling wind detoxifcation, blood circulation promoting and blood stasis dispelling, pain relieving.
Radix Bupleuri-reconciling superficies and interior, soothing the liver yang invigorating is usually used in analgesic, calm, analgesia, antitussive.
Rhizoma Chuanxiong-blood-activating and qi-promoting, wind-expelling pain-stopping.
Radix Codonopsis-invigorating the spleen and replenishing QI, the spleen invigorating lung benefiting.Be used for deficiency of the spleen and lung, the cardiopalmus of breathing hard, the dyspnea due to deficiency cough, interior-heat is quenched one's thirst.
Fructus Aurantii-the chest stuffiness relieving of regulating the flow of vital energy, the stagnant removing food stagnancy of row.
Radix Platycodonis-bitter in the mouth is flat; Lung qi dispersing eliminates the phlegm, the sore-throat relieving evacuation of pus.
Periostracum Cicadae-suffering, sweet, cold, expelling wind to relieve convulsion
Bombyx Batryticatus-expelling wind for relieving convulsion, dissipating phlegm and resolving masses.
Scorpio-the spasmolytic that relieves dizziness, high fever, infantile convulsions, epilepsy, etc., antiinflammatory counteracting toxic substances, removing obstruction in the collateral to relieve pain
Scolopendra-endogenous wind stopping is separated hydroxyl, is usually used in wind disease convulsion pain
Radix Isatidis-heat clearing away, detoxifcation, removing heat from blood.
Rhizoma Zingiberis Recens-acrid in the mouth tepor, expelling cold and relieving exterior syndrome, exorcising cold and heat; Be usually used in diseases such as anemofrigid cold.
The flat sweet in the mouth of Radix Glycyrrhizae-property, but invigorating the spleen and replenishing QI are grown and to be coughed lung moistening, and cough-relieving is quenched the thirst, and are in harmonious proportion hundred medicines.
Radix Peucedani-suffering, bitter is slightly cold, the wind heat clearing away of loosing, lowering the adverse-rising QI to resolve phlegm.Be usually used in the cough due to pathogenic wind-heat, abundant expectoration asthma.
Herba Menthae-suffering is to disperse, and is cool to heat clearing away, clear light cool loosing, and it is the product commonly used of dispelling wind and heat pathogens.
Poria-spleen invigorating eliminating dampness by diuresis, mind tranquilizing and the heart calming.
The clinical drug effect checking of Chinese medicine composition of the present invention:
One, the preparation of one of test medicine of the present invention " on feel sheet ":
With weight portion ratio (can allow ± 5% variation), ratio in 10 parts of 15 parts of Radix Codonopsis, 10 parts in Poria, 10 parts of Rhizoma Chuanxiongs, 10 parts of Radix Saposhnikoviaes, 15 parts of Rhizoma Et Radix Notopterygiis, 10 parts of Fructus Aurantiis, 10 parts of Herba Menthaes, 5 parts of Radix Platycodoniss and Radix Peucedanis is got Chinese crude drug ready, crushed after being dried becomes fine powder, and is standby behind the 80-120 order dusting cover excessively; Get the ratio of 10 parts of Herba Schizonepetae, 10 parts of Radix Angelicae Pubescentiss, 10 parts of Radix Bupleuri, 10 parts of Periostracum Cicadae, 10 parts of Bombyx Batryticatus, 5 parts of Scorpio, 5 parts of Scolopendras, 30 parts of Radix Isatidis, 5 parts in Rhizoma Zingiberis Recens, 10 parts in Radix Glycyrrhizae ready Chinese crude drug again, extract twice with decocting, each 1-2 hours, extracted twice liquid being merged and be condensed into relative concentration was 1.35-1.38 thick paste; Thick paste and above-mentioned standby fine powder are mixed, dried, pulverize the back then and cross 80-120 order dusting cover, add 10% starch slurry and make soft material, and then oven dry, granulate, add 6% Pulvis Talci tabletting, at last with packing behind the ultraviolet disinfection after 18 mesh sieve corning.The specification of this tablet is 0.4 gram/sheet, and its character is a sepia, feeble QI, bitter in the mouth.
Two, instructions of taking:
Morning, noon and afternoon every day service once, and each 6, warm water delivery service.
Three, treatment time:
Pay no attention to continuously and take 5 days courses of treatment disconnectedly.
Four, identifying object and therapeutic outcome:
In recent years, the clinical treatment that " on feel sheet " is applied to state, Changji institute of traditional Chinese medicine reaches thousands of routine patients, by observation analysis to clinical data, prove the present invention for improving fever, headache, watery nasal discharge, the nasal obstruction that causes because of flu, various diseases such as laryngopharynx swelling and pain all have comparatively satisfied curative effect.Now only 2005-2,006 two years clinical inpatients are added up for 476 person-times, healing reaches 337 person-times, transfers 115 person-times well to, and invalid is 24 person-times, and cure rate can reach 70%, and total effective rate can reach 95%.
Five, untoward reaction: all case is not seen untoward reaction, provable its safety.
Six, conclusion:
Practice according to traditional Chinese medical science pharmacology and clinical treatment can draw: " on feel sheet " has the effect and the effect of diseases such as good curing wind and cold diseases caused by exogenous pathogenic factor really, can be widely used in clinical treatment and use.
" on feel sheet " who produces based on the compatibility of Chinese medicine of the present invention for many years at the significant curative effect of diseases such as treatment flu, fever watery nasal discharge, laryngopharynx swelling and pain, has been used for the hospital preparation of clinical treatment based on it by the approval of medicine prison department of local autonomous region.
The specific embodiment
The preparation of embodiment 1, extract
Weight portion ratio according to 10 parts of Herba Schizonepetae, 10 parts of Radix Saposhnikoviaes, 15 parts of Rhizoma Et Radix Notopterygiis, 10 parts of Radix Angelicae Pubescentiss, 10 parts of Radix Bupleuri, 10 parts of Rhizoma Chuanxiongs, 15 parts of Radix Codonopsis, 10 parts in Poria, 10 parts of Fructus Aurantiis, 5 parts of Radix Platycodoniss, 10 parts of Periostracum Cicadae, 10 parts of Bombyx Batryticatus, 5 parts of Scorpio, 5 parts of Scolopendras, 30 parts of Radix Isatidis, 5 parts in Rhizoma Zingiberis Recens, 10 parts in Radix Glycyrrhizae, 10 parts of Radix Peucedanis, 10 parts of Herba Menthaes is got raw material of Chinese medicine ready, twice of the water boiling and extraction that adds 8 times of amounts, merge routinely and filter, leave standstill, filter, concentrating under reduced pressure becomes extractum, and this extractum is active component extract.
The preparation of embodiment 2, oral agents
The active component extract that embodiment 1 extracted is equipped with corresponding medicinal adjuvant (dextrin, magnesium stearate etc.) can adopt conventional pharmaceutical technology can make dosage forms such as granule and capsule.
Embodiment 3, fine powder mince or the preparation of powder
According to Herba Schizonepetae 8-12 part, Radix Saposhnikoviae 8-12 part, Rhizoma Et Radix Notopterygii 12-18 part, Radix Angelicae Pubescentis 8-12 part, Radix Bupleuri 8-12 part, Rhizoma Chuanxiong 8-12 part, Radix Codonopsis 12-18 part, Poria 8-12 part, Fructus Aurantii 8-12 part, Radix Platycodonis 4-6 part, Periostracum Cicadae 8-12 part, Bombyx Batryticatus 8-12 part, Scorpio 4-6 part, Scolopendra 4-6 part, Radix Isatidis 25-35 part, Rhizoma Zingiberis Recens 4-6 part, Radix Glycyrrhizae 8-12 part, Radix Peucedani 8-12 part, the weight portion ratio of Herba Menthae 8-12 part is got Chinese crude drug ready, crushed after being dried becomes fine powder, cross 80-120 order dusting cover, get again and can get fine powder behind the fine powder dry heat sterilization and mince, directly be powder (can take after mixing it with hot water) after the pack.
The preparation of embodiment 4, tablet 1
With weight portion ratio (can allow ± 5% variation), ratio in 8 parts of 12 parts of Radix Codonopsis, 8 parts in Poria, 8 parts of Rhizoma Chuanxiongs, 8 parts of Radix Saposhnikoviaes, 12 parts of Rhizoma Et Radix Notopterygiis, 8 parts of Fructus Aurantiis, 8 parts of Herba Menthaes, 4 parts of Radix Platycodoniss and Radix Peucedanis is got Chinese crude drug ready, crushed after being dried becomes fine powder, and is standby behind the 80-120 order dusting cover excessively; Get the ratio of 8 parts of Herba Schizonepetae, 8 parts of Radix Angelicae Pubescentiss, 8 parts of Radix Bupleuri, 8 parts of Periostracum Cicadae, 8 parts of Bombyx Batryticatus, 4 parts of Scorpio, 4 parts of Scolopendras, 25 parts of Radix Isatidis, 4 parts in Rhizoma Zingiberis Recens, 8 parts in Radix Glycyrrhizae ready Chinese crude drug again, extract twice with decocting, each 1-2 hours, extracted twice liquid being merged and be condensed into relative concentration was 1.35-1.38 thick paste; Thick paste and above-mentioned standby fine powder are mixed, dried, pulverize the back then and cross 80-120 order dusting cover, add 10% starch slurry and make soft material, and then oven dry, granulate, add 6% Pulvis Talci tabletting, at last with packing behind the ultraviolet disinfection after 18 mesh sieve corning.
The preparation of embodiment 5, tablet 2
With weight portion ratio (can allow ± 5% variation), ratio in 12 parts of 18 parts of Radix Codonopsis, 12 parts in Poria, 12 parts of Rhizoma Chuanxiongs, 12 parts of Radix Saposhnikoviaes, 18 parts of Rhizoma Et Radix Notopterygiis, 12 parts of Fructus Aurantiis, 12 parts of Herba Menthaes, 6 parts of Radix Platycodoniss and Radix Peucedanis is got Chinese crude drug ready, crushed after being dried becomes fine powder, and is standby behind the 80-120 order dusting cover excessively; Get the ratio of 12 parts of Herba Schizonepetae, 12 parts of Radix Angelicae Pubescentiss, 12 parts of Radix Bupleuri, 12 parts of Periostracum Cicadae, 12 parts of Bombyx Batryticatus, 6 parts of Scorpio, 6 parts of Scolopendras, 35 parts of Radix Isatidis, 6 parts in Rhizoma Zingiberis Recens, 8 parts in Radix Glycyrrhizae ready Chinese crude drug again, extract twice with decocting, each 1-2 hours, extracted twice liquid being merged and be condensed into relative concentration was 1.35-1.38 thick paste; Thick paste and above-mentioned standby fine powder are mixed, dried, pulverize the back then and cross 80-120 order dusting cover, add 10% starch slurry and make soft material, and then oven dry, granulate, add 6% Pulvis Talci tabletting, at last with packing behind the ultraviolet disinfection after 18 mesh sieve corning.
Present invention focuses on to provide a kind of Chinese medicine preparation that is used for the treatment of diseases such as flu; its core is each component and proportioning thereof; can make various oral formulations with existing conventional pharmaceutical processing technology; above example just exemplifies the simple embodiment that is suitable for of the present invention; under the situation that does not deviate from the invention spirit and essence thereof; be familiar with all equivalent variations of making according to the present invention of those of ordinary skill in the art, all should belong to the protection domain that claims of the present invention limit.
Claims (4)
1, a kind of Chinese medicine preparation for the treatment of flu, it is made up of monarch drug, ministerial drug, adjuvant drug and messenger drug four class medicines and adopts existing conventional pharmaceutical technology (tcd) and adjuvant and the oral formulations made by following bulk drugs; Wherein, described monarch drug weight portion is: Herba Schizonepetae 8-12 part, Radix Saposhnikoviae 8-12 part, Rhizoma Et Radix Notopterygii 12-18 part, Radix Angelicae Pubescentis 8-12 part; Described ministerial drug weight portion is: Radix Bupleuri 8-12 part, Rhizoma Chuanxiong 8-12 part, Radix Codonopsis 12-18 part, Poria 8-12 part; Described adjuvant drug weight portion is: Fructus Aurantii 8-12 part, Radix Platycodonis 4-6 part, Periostracum Cicadae 8-12 part, Bombyx Batryticatus 8-12 part, Scorpio 4-6 part, Scolopendra 4-6 part, Radix Isatidis 25-35 part; Described messenger drug weight portion is: Rhizoma Zingiberis Recens 4-6 part, Radix Glycyrrhizae 8-12 part, Radix Peucedani 8-12 part, Herba Menthae 8-12 part.
2, the Chinese medicine preparation of treatment flu according to claim 1, wherein, described monarch drug weight portion is: 10 parts of Herba Schizonepetae, 10 parts of Radix Saposhnikoviaes, 15 parts of Rhizoma Et Radix Notopterygiis, 10 parts of Radix Angelicae Pubescentiss; Described ministerial drug weight portion is: 10 parts of Radix Bupleuri, 10 parts of Rhizoma Chuanxiongs, 15 parts of Radix Codonopsis, 10 parts in Poria; Described adjuvant drug weight portion is: 10 parts of Fructus Aurantiis, 5 parts of Radix Platycodoniss, 10 parts of Periostracum Cicadae, 10 parts of Bombyx Batryticatus, 5 parts of Scorpio, 5 parts of Scolopendras, 30 parts of Radix Isatidis; Described messenger drug weight portion is: 5 parts in Rhizoma Zingiberis Recens, 10 parts in Radix Glycyrrhizae, 10 parts of Radix Peucedanis, 10 parts of Herba Menthaes.
3, the Chinese medicine preparation of treatment flu according to claim 1 and 2, wherein, described oral formulations includes water decoction, pill, granule, capsule, powder, tablet or the oral liquid made from existing conventional pharmaceutical technology (tcd) and adjuvant.
4, the application of Chinese medicine composition according to claim 1 and 2 in the Chinese medicine preparation of preparation treatment flu.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008100729548A CN101361952A (en) | 2008-09-19 | 2008-09-19 | Traditional Chinese medicine preparation for treating cold |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008100729548A CN101361952A (en) | 2008-09-19 | 2008-09-19 | Traditional Chinese medicine preparation for treating cold |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101361952A true CN101361952A (en) | 2009-02-11 |
Family
ID=40388680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2008100729548A Pending CN101361952A (en) | 2008-09-19 | 2008-09-19 | Traditional Chinese medicine preparation for treating cold |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101361952A (en) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101755975A (en) * | 2010-01-25 | 2010-06-30 | 中山市新运来医药科技开发有限公司大涌分公司 | Chinese herbal medicine sugar and tea drink preparation for preventing and treating cold |
| CN102370863A (en) * | 2011-11-22 | 2012-03-14 | 王洪强 | Traditional Chinese medicine for treating bronchial asthma |
| CN102716236A (en) * | 2012-06-16 | 2012-10-10 | 李承平 | Qi benefiting and superficies syndrome relieving tablet set |
| CN103251714A (en) * | 2013-04-02 | 2013-08-21 | 余姚市禽畜病防治研究所 | Chinese medicinal composition treating duck Tembusu virus |
| CN103251821A (en) * | 2013-06-03 | 2013-08-21 | 肖变化 | Medicine for treating wind-heat headache and migraine headache and preparation method of medicine |
| CN103356756A (en) * | 2013-06-26 | 2013-10-23 | 柳晖 | Traditional Chinese medicine composition for treating allergic rhinitis |
| CN104288265A (en) * | 2014-11-04 | 2015-01-21 | 禤燕华 | Traditional Chinese medicinal composition for treating acute laryngitis |
| CN105943767A (en) * | 2016-06-02 | 2016-09-21 | 王平安 | Trinity cold medicine |
| CN107669998A (en) * | 2017-09-28 | 2018-02-09 | 广西民族大学 | A kind of Chinese medicine for treating flu |
| CN114073731A (en) * | 2020-08-14 | 2022-02-22 | 鲁南制药集团股份有限公司 | A Chinese medicinal composition for treating abdominal pain and diarrhea |
| CN114146122A (en) * | 2020-09-08 | 2022-03-08 | 鲁南制药集团股份有限公司 | Traditional Chinese medicine composition for treating anorexia |
| CN114146121A (en) * | 2020-09-08 | 2022-03-08 | 鲁南制药集团股份有限公司 | Application of traditional Chinese medicine composition in preparation of medicine for treating dyspepsia |
-
2008
- 2008-09-19 CN CNA2008100729548A patent/CN101361952A/en active Pending
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101755975A (en) * | 2010-01-25 | 2010-06-30 | 中山市新运来医药科技开发有限公司大涌分公司 | Chinese herbal medicine sugar and tea drink preparation for preventing and treating cold |
| CN102370863A (en) * | 2011-11-22 | 2012-03-14 | 王洪强 | Traditional Chinese medicine for treating bronchial asthma |
| CN102716236A (en) * | 2012-06-16 | 2012-10-10 | 李承平 | Qi benefiting and superficies syndrome relieving tablet set |
| CN103251714B (en) * | 2013-04-02 | 2014-08-06 | 余姚市禽畜病防治研究所 | Chinese medicinal composition treating duck Tembusu virus |
| CN103251714A (en) * | 2013-04-02 | 2013-08-21 | 余姚市禽畜病防治研究所 | Chinese medicinal composition treating duck Tembusu virus |
| CN103251821A (en) * | 2013-06-03 | 2013-08-21 | 肖变化 | Medicine for treating wind-heat headache and migraine headache and preparation method of medicine |
| CN103356756A (en) * | 2013-06-26 | 2013-10-23 | 柳晖 | Traditional Chinese medicine composition for treating allergic rhinitis |
| CN103356756B (en) * | 2013-06-26 | 2014-12-10 | 刘姣 | Traditional Chinese medicine composition for treating allergic rhinitis |
| CN104288265A (en) * | 2014-11-04 | 2015-01-21 | 禤燕华 | Traditional Chinese medicinal composition for treating acute laryngitis |
| CN105943767A (en) * | 2016-06-02 | 2016-09-21 | 王平安 | Trinity cold medicine |
| CN107669998A (en) * | 2017-09-28 | 2018-02-09 | 广西民族大学 | A kind of Chinese medicine for treating flu |
| CN114073731A (en) * | 2020-08-14 | 2022-02-22 | 鲁南制药集团股份有限公司 | A Chinese medicinal composition for treating abdominal pain and diarrhea |
| CN114146122A (en) * | 2020-09-08 | 2022-03-08 | 鲁南制药集团股份有限公司 | Traditional Chinese medicine composition for treating anorexia |
| CN114146121A (en) * | 2020-09-08 | 2022-03-08 | 鲁南制药集团股份有限公司 | Application of traditional Chinese medicine composition in preparation of medicine for treating dyspepsia |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101361952A (en) | Traditional Chinese medicine preparation for treating cold | |
| CN100344313C (en) | Chinese patent drug for treating infantile cold and repeated cold, and its prepn. method | |
| CN103463609A (en) | Traditional Chinese medicine oral decoction for treating upper respiratory infection and preparation method for Chinese patent medicine of traditional Chinese medicine oral decoction | |
| CN101181393A (en) | Chinese medicine preparation for curing common cold and producing method thereof | |
| CN104587298A (en) | Traditional Chinese medicinal composition for treating pulmonary abscess | |
| CN116139237B (en) | A Chinese medicinal composition for preventing and treating respiratory tract infection caused by coronavirus, and its application | |
| CN105288406A (en) | Traditional Chinese medicine preparation for treating bronchitis due to deficiency of both lung and spleen as well as preparation method thereof | |
| CN104758529A (en) | Traditional Chinese medicine composition for treating common cold due to wind-cold | |
| CN105079444A (en) | Traditional Chinese medicine composition for treating bronchial asthma | |
| CN101336998B (en) | Traditional Chinese medicine for treating whelk | |
| CN100998820A (en) | Orall Chinese medicine for treating damp-evil type cold | |
| CN101856488A (en) | Chinese medicament for treating tracheitis | |
| CN105617042A (en) | Traditional Chinese medicine composition for treating headache | |
| CN1994437A (en) | Orally administered Chinese medicine for treating cold | |
| CN104173830A (en) | Medicament for reconciling interior syndromes and relieving exterior syndromes for high fever of cold in winter and preparation method thereof | |
| CN1698848A (en) | Medicine with cough and asthma stopping and lung moistening functions and its preparation process | |
| CN104721767A (en) | Chinese medicinal composition for treatment of children cough and preparation method thereof | |
| CN102228567A (en) | Medicine for treating trigeminal neuralgia | |
| CN1813876A (en) | Xian Pengliaofu oral preparation-a Chinese medicine for treating bone disease | |
| CN1225266A (en) | Liquid medicine for treating cold | |
| CN105396105A (en) | A method of preparing a traditional Chinese medicine composition for preventing and treating recurrent common cold in children | |
| CN105362999A (en) | Traditional Chinese medicine preparation for preventing and treating infantile repeated cold and preparation method thereof | |
| CN106578183A (en) | Anti-diarrhea black tea composition and preparing method | |
| CN114796430A (en) | Traditional Chinese medicine formula with effect of preventing and treating 2019 novel coronavirus | |
| CN105250687A (en) | Traditional Chinese medicine composition for treating bronchiectasis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20090211 |